Literature DB >> 21904499

Healing of leg ulcers associated with transjugular intrahepatic portosystemic shunt in decompensated cirrhosis: case series of a possible hepatodermal syndrome.

Cherif M El Younis1, Nora V Bergasa.   

Abstract

The occurrence of leg ulcers in patients with cirrhosis is not well documented in the literature. In this case series, we describe 4 patients with cirrhosis complicated by leg ulceration that failed all conventional therapy, yet healed completely following the placement of transjugular intrahepatic portosystemic shunt. The course of disease and the possibility of a hepatodermal syndrome underlying this observation are discussed.

Entities:  

Keywords:  Cirrhosis; leg ulcers; shunts; transjugular intrahepatic portosystemic

Year:  2008        PMID: 21904499      PMCID: PMC3088300     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  13 in total

1.  Inducible nitric oxide synthase expression in chronic viral hepatitis and its relation with histological severity of disease.

Authors:  O Kandemir; A Polat; A Kaya
Journal:  J Viral Hepat       Date:  2002-11       Impact factor: 3.728

Review 2.  Management of venous leg ulcers.

Authors:  Deborah A Simon; Francis P Dix; Charles N McCollum
Journal:  BMJ       Date:  2004-06-05

3.  Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites.

Authors:  J W Ferguson; A R Dover; S Chia; N L M Cruden; P C Hayes; D E Newby
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

Review 4.  Transjugular intrahepatic portosystemic shunt.

Authors:  Andreas Ochs
Journal:  Dig Dis       Date:  2005       Impact factor: 2.404

Review 5.  Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles.

Authors:  W G Jiang; S Hiscox
Journal:  Histol Histopathol       Date:  1997-04       Impact factor: 2.303

6.  Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers.

Authors:  S A Abd-El-Aleem; M W Ferguson; I Appleton; S Kairsingh; E B Jude; K Jones; C N McCollum; G W Ireland
Journal:  J Pathol       Date:  2000-08       Impact factor: 7.996

Review 7.  Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome.

Authors:  Søren Møller; Flemming Bendtsen; Jens H Henriksen
Journal:  Scand J Gastroenterol       Date:  2005-05       Impact factor: 2.423

Review 8.  Growth factors and the gastrointestinal tract.

Authors:  M S Murphy
Journal:  Nutrition       Date:  1998-10       Impact factor: 4.008

9.  Hepatocyte growth factor may accelerate healing in chronic leg ulcers: a pilot study.

Authors:  F Nayeri; T Strömberg; M Larsson; L Brudin; C Söderström; P Forsberg
Journal:  J Dermatolog Treat       Date:  2002-06       Impact factor: 3.359

Review 10.  Management of leg ulcers.

Authors:  Jonathan Kantor; David J Margolis
Journal:  Semin Cutan Med Surg       Date:  2003-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.